This Monday, the multinational American consumer goods and personal care company, Kimberly Clark, announced the purchase of Kenvue, maker of Tylenol, for a million-dollar sum.

In the merger valued at approximately $48.7 billion, Mike Hsu, CEO of Kimberly-Clark stated, “We will serve billions of consumers at every stage of life.” According to the agreement, Kenvue shareholders will receive $3.50 in cash per share, and the company will remain at Kimberly-Clark's headquarters in Irving, Texas. It was also revealed that Kenvue shareholders will own approximately 46%, while Kimberly-Clark shareholders will own approximately 54%. This has been one of the most significant mergers announced this year, as both companies own well-known brands such as Kenvue's Listerine and Neutrogena; and Kleenex and Kimberly-Clark's Scott.

Finally, these transactions are expected to be finalized by the middle of next year, once the shareholders of both companies have concluded with the approval of all agreements.

This news has been tken from authentic news syndicates and agencies and only the wordings has been changed keeping the menaing intact. We have not done personal research yet and do not guarantee the complete genuinity and request you to verify from other sources too.